Rupesh Dash Selected Research

AD 5

1/2014	Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).
5/2012	Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.
3/2011	A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
6/2010	Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rupesh Dash Research Topics

Disease

43	Neoplasms (Cancer) 12/2021 - 03/2009
23	Melanoma (Melanoma, Malignant) 12/2021 - 03/2009
9	Prostatic Neoplasms (Prostate Cancer) 05/2015 - 03/2010
8	Squamous Cell Carcinoma of Head and Neck 06/2021 - 04/2015
8	Infections 01/2021 - 03/2010
6	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2011
4	Mouth Neoplasms (Oral Cancer) 05/2018 - 04/2015
4	Carcinoma (Carcinomatosis) 10/2017 - 02/2010
4	Glioma (Gliomas) 10/2011 - 01/2010
3	Breast Neoplasms (Breast Cancer) 06/2013 - 04/2010
2	COVID-19 11/2022 - 01/2021
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021 - 05/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2015 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 10/2012 - 05/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2011 - 04/2010
2	Leukemia 12/2010 - 05/2010
2	Glioblastoma (Glioblastoma Multiforme) 06/2010 - 02/2010
1	Convalescence 01/2021
1	Carcinogenesis 01/2020
1	Lymphatic Metastasis 10/2017
1	Adenocarcinoma 10/2012
1	Colorectal Neoplasms (Colorectal Cancer) 05/2012
1	Huntington Disease (Huntington's Disease) 10/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2011
1	Alzheimer Disease (Alzheimer's Disease) 10/2011
1	Kidney Neoplasms (Kidney Cancer) 03/2011

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2009
14	InterleukinsIBA 01/2014 - 02/2010
13	CytokinesIBA 05/2015 - 02/2010
8	Pharmaceutical PreparationsIBA 01/2021 - 08/2009
7	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 02/2010
6	1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamideIBA 06/2015 - 05/2010
6	Interleukin-10 (Interleukin 10)IBA 05/2012 - 05/2010
6	CeramidesIBA 09/2011 - 02/2010
4	AD 5IBA 01/2014 - 06/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 02/2011
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
3	Celecoxib (Celebrex)FDA Link 06/2015 - 05/2011
3	apogossypolIBA 05/2012 - 05/2010
2	InterferonsIBA 12/2021 - 01/2012
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2014
2	KetorolacIBA 01/2020 - 04/2015
2	SaltsIBA 01/2020 - 04/2015
2	6-methyladenineIBA 01/2020 - 01/2020
2	Docetaxel (Taxotere)FDA Link 12/2019 - 02/2011
2	CarcinogensIBA 06/2015 - 04/2015
2	CaspasesIBA 06/2015 - 01/2012
2	SynteninsIBA 01/2013 - 01/2012
2	Glutamic Acid (Glutamate)FDA Link 10/2011 - 10/2011
2	CalpainIBA 09/2011 - 05/2010
2	Tyrosine Kinase InhibitorsIBA 02/2011 - 04/2010
2	vandetanib (ZD6474)IBA 02/2011 - 04/2010
2	Antineoplastic Agents (Antineoplastics)IBA 02/2011 - 05/2010
2	ErbB Receptors (EGF Receptor)IBA 02/2011 - 04/2010
2	Small Interfering RNA (siRNA)IBA 12/2010 - 01/2010
2	Endoplasmic Reticulum Chaperone BiPIBA 12/2010 - 03/2010
2	Phosphotransferases (Kinase)IBA 04/2010 - 02/2010
1	16S Ribosomal RNAIBA 11/2022
1	LigandsIBA 01/2021
1	Cyclin D1IBA 01/2021
1	CateninsIBA 01/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021
1	ProteomeIBA 01/2021
1	MethyltransferasesIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	RNA Helicases (RNA Helicase)IBA 01/2020
1	triptolideIBA 12/2019
1	Fluorouracil (Carac)FDA LinkGeneric 12/2019
1	ElementsIBA 10/2017
1	fascinIBA 10/2017
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2015
1	Tetracycline (Achromycin)FDA LinkGeneric 06/2015
1	Minocycline (Cyclops)FDA LinkGeneric 06/2015
1	BH 3IBA 05/2015
1	DEAD-box RNA HelicasesIBA 04/2015
1	Mitogen-Activated Protein Kinase 3IBA 01/2014
1	p38 Mitogen-Activated Protein KinasesIBA 01/2014
1	IntegrinsIBA 06/2013
1	Fibronectins (Fibronectin)IBA 06/2013
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2013
1	Insulin (Novolin)FDA Link 01/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	GossypolIBA 11/2012
1	AEE 788 (AEE788)IBA 10/2012
1	ClusterinIBA 05/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 10/2011
1	Autophagy-Related Protein 5IBA 09/2011
1	ABT-737IBA 05/2011
1	ChitosanIBA 05/2011
1	Durapatite (Hydroxylapatite)IBA 05/2011
1	Aligeron (AS 2)IBA 03/2011

Therapy/Procedure

26	Therapeutics 01/2021 - 03/2009
9	Drug Therapy (Chemotherapy) 01/2021 - 03/2009
2	Radiotherapy 01/2020 - 03/2009
1	Injections 12/2021
1	Immunotherapy 01/2020
1	Microbubbles 05/2015